Concepedia
Statistics
Publications
3
Citations
125
H-Index
Active since
2005
Affiliations
Sarah Cannon(Current)
The University of Texas MD Anderson Cancer Center
Gerald Falchook is an author at Sarah Cannon specializing in oncology, cancer therapeutics, and radiation oncology.
Top concepts
MedicineOncologyCancer TherapyRadiation OncologyPathologyPharmacologyCancer ResearchPharmacotherapySurgical OncologyMolecular Oncology
Publications per year
2005–2016
Phase I trial of oral talactoferrin alfa in refractory solid tumors
Teresa G. Hayes, Gerald Falchook, Gauri R. Varadhachary et al. · Investigational New Drugs · 2005 · 101 citations
Surgical Oncology, Medicine, Oral Talactoferrin Alfa +8
Phase I combination of pazopanib and everolimus in PIK3CA mutation positive/PTEN loss patients with advanced solid tumors refractory to standard therapy
Heloisa Veasey Rodrigues, Danxia Ke, JoAnn Lim et al. · Investigational New Drugs · 2015 · 14 citations
Medicine, Metronomic Therapy, Pathology +5
Phase I clinical trial of lenalidomide in combination with 5-fluorouracil, leucovorin, and oxaliplatin in patients with advanced cancer
Rabih Said, Yang Ye, David S. Hong et al. · Cancer Chemotherapy and Pharmacology · 2016 · 10 citations
1–3 of 3